Abstract
Combining radiation and immune checkpoint blockade provides synergistic antitumor responses in animal models and a small subset of patients. New preclinical data have provided mechanistic insight into this treatment interaction and identification of therapeutic targets to optimize this approach.
Original language | English (US) |
---|---|
Pages (from-to) | 463-465 |
Number of pages | 3 |
Journal | Trends in Molecular Medicine |
Volume | 21 |
Issue number | 8 |
DOIs | |
State | Published - Aug 1 2015 |
Keywords
- Cancer
- Immunotherapy
- Radiation
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology